logo
A Turning Point in Colon Cancer: Young People Are Finding It Earlier

A Turning Point in Colon Cancer: Young People Are Finding It Earlier

Hindustan Times6 hours ago
People under age 50 have been appearing increasingly at doctor's offices in the past few decades, complaining of blood in their stool or bowel or of abdominal trouble or unexplained weight loss. The diagnosis: colorectal cancer . And by that time, it was often too late.
But that paradigm is finally starting to shift, at least for patients in their 40s.
There has been a jump in people aged 45 to 49 getting screened for colorectal cancer, after recent medical guidelines lowered the screening age for those at average risk. As a result, the disease is being caught sooner, when it is more curable and the treatment is less grueling, according to new research from the American Cancer Society.
The recent screening recommendations designed to catch cases sooner appear to be working.
'It's thrilling to see this,' said Rebecca Siegel, an epidemiologist at the ACS and an author of the new research. 'It means fewer deaths and higher quality of life for people who are diagnosed.'
The findings come in a flurry of research published Monday in the Journal of the American Medical Association. Colorectal cancer screening in the U.S. for adults age 45 to 49 increased by 62% from 2019 to 2023, according to one ACS paper. Early-stage diagnoses then surged, including a 50% relative increase from 2021 to 2022, according to another ACS report.
A trial of more than 20,000 people in the same age bracket was published by a separate group of researchers, showing that testing uptake increases when people are mailed stool tests by default, versus when they are asked if they want a test or a colonoscopy. Screening rates in the trial were low, however, with 19% of people in the trial overall opting to get screened.
'We probably shouldn't be wasting time asking patients first; we should send them what they need,' said Dr. Folasade May, the trial's senior author and a gastroenterologist at the University of California, Los Angeles. 'We have a long way to go.'
Colorectal cancer rates have been rising for people under age 50 since the 1990s, and the disease is now the leading cause of cancer death among men in that group. Researchers are investigating everything from diet and lifestyle to environmental contaminants, to figure out why colorectal and other cancers are rising in younger adults.
The ACS in 2018 started recommending that people with average risk as young as 45 years old get screened for colorectal cancer, down from the previous start of age 50. The U.S. Preventive Services Task Force followed in 2021; their guidelines carry particular weight among primary-care providers and often lead to health-insurance coverage.
Suddenly, millions of people were newly overdue for screening. For people in that 45-to-49 age bracket, cases jumped, going from about a 1% increase in the incidence rate each year since 2004 to a 12% annual rise from 2019 to 2022, the data show. The rise was driven by diagnoses of early-stage disease.
A post-Covid rebound in people seeking healthcare could contribute to some of the increase, researchers said, but the change in screening guidance is likely the bigger factor. The trend looks similar to what happened among people ages 50 and above in the late 1990s, after screening was first recommended for them, said Caitlin Murphy, a cancer epidemiologist and professor of pediatrics at the University of Chicago, who wasn't involved in the studies.
It will still take time to see what the impact on deaths looks like for the newly eligible, she said. 'Ultimately, the goal of screening is to reduce mortality, and we haven't seen that quite yet, simply because not enough time has gone by.'
Up-to-date screening via colonoscopy for those aged 45 to 49 rose from around 20% of people in 2019 to about 28% in 2023, according to one of the ACS reports. A colonoscopy is the gold-standard test that also helps doctors remove polyps to actually prevent the cancer from forming. Alternatively, use of tests that look for blood or DNA changes in the stool also increased, rising from 1.3% to 7.1% in that age group.
Screening rates remained mostly stable in all other age groups, the report found.
Screening rates also remained unchanged for people ages 45 to 49 with less than a high-school education or who are uninsured. And they still trail behind those for older adults, who remain at higher risk. Factors including genetics, excess body weight, smoking cigarettes and a diet heavy in red and processed meats also increase a person's odds of developing the disease.
People in the 45-to-49 age bracket account for nearly half of all colorectal cancers under age 50, ACS said. But that still leaves a lot of people who are at risk and are too young to be screened.
'I have patients in their 20s in my practice that would never fit the guidelines,' said Dr. Michael Cecchini, a medical oncologist and colorectal cancer specialist at Yale Cancer Center. 'We need to be thinking about it on our list of possible diagnoses.'
Write to Brianna Abbott at brianna.abbott@wsj.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

India's pandemic toll remains elusive
India's pandemic toll remains elusive

The Hindu

timean hour ago

  • The Hindu

India's pandemic toll remains elusive

The Civil Registration System (CRS) data has brought into sharp relief the magnitude of excess mortality that India witnessed during the COVID-19 pandemic years. Excess mortality refers to the difference between the total number of deaths during a pandemic or any other natural disaster compared to the number of deaths that would have been expected under normal conditions. According to the CRS, India recorded 76.4 lakh deaths in 2019. This figure rose to 81.11 lakh in 2020 and further surged to 1.02 crore in 2021 — an implicit acknowledgement of the fact that the true mortality impact of COVID-19 far exceeds the official toll of 5.33 lakh. Data from the Medical Certification of Cause of Death (MCCD) for 2021, released alongside the CRS and Sample Registration System reports, adds further weight to this claim. COVID-19 was identified as the second leading cause of death, with 5.74 lakh certified fatalities attributed to the virus — already exceeding the official figure. However, this estimate was drawn from less than a quarter (23.4%) of registered deaths in 2021. Taken together, the rise in all-cause mortality and the limited scope of medical certification offer a compelling case that India's true pandemic death toll may be far closer to the World Health Organization's estimate of 47 lakh deaths — a model that the Government of India had earlier rejected, citing concerns over its methodological robustness. A systemic deficiency CRS data/all-cause mortality data is indispensable, especially given the widespread undercounting of COVID-related deaths. This metric captures not only confirmed cases but also fatalities arising from misdiagnoses, misclassification, and pandemic-induced systemic disruptions. Nonetheless, the utility of the all-cause mortality data in gauging the true impact of COVID-19 is limited in the Indian setting, as the recording of deaths is far from universal. The National Family Health Survey-5 states that nearly 29% of deaths between 2016 and 2020 went unregistered. The omission of civil registration from the list of essential services during the 2020 lockdown further obscured the mortality landscape. As a consequence, even comprehensive datasets such as CRS may fall short in reflecting the full impact of the pandemic. Editorial | A belated admission: On the undercount of India's COVID-19 pandemic deaths Beyond numerical discrepancies lies a deeper issue — the structural inadequacy of death certification and classification. During the pandemic years, we visited crematoriums and burial grounds in a locality in Kerala. We observed a marked rise in the number of daily cremations compared to previous years — an increase that was evident not only in facilities designated for handling COVID-19 deaths, but also in those without such designation. This raises pertinent questions regarding the misclassification of COVID-19 deaths and under-ascertainment of causes. A significant driver of this opacity is the absence of medical certification. In 2020, 45% of deaths occurred without any form of medical attention — 10% points higher than in pre-pandemic years. Within our study cohort, only 22.8% of the deceased had any formal medical documentation indicating the cause of death. Nationally, only 23.4% of deaths are medically certified as per the recent MCCD data. This systemic deficiency compromises mortality surveillance as well as public health planning. Indirect deaths A further dimension of the pandemic's mortality burden relates to indirect deaths — a category of deaths that, while not directly caused by SARS-CoV-2 infection, can be reasonably attributed to the wider repercussions of the pandemic. These fatalities, often absent from COVID-19 official statistics, occurred due to systemic disruptions: delays in seeking care due to fear of infection, scarcity of hospital beds and essential medicines, post-infection complications, economic distress, and logistical barriers to healthcare access during prolonged lockdowns. During our field study, we found that a considerable share of deaths was indirectly linked to these cascading effects of the pandemic. Many people suffered physical and psychological deterioration post-infection, some experienced an exacerbation of chronic conditions, and others refrained from seeking timely medical attention. When extrapolated to the broader national context, particularly in regions where healthcare systems are fragile and supply chains were acutely disrupted, the implications would be sobering. To gauge the true mortality impact of the pandemic, it is insufficient therefore to rely solely on officially recorded COVID-19 deaths or all-cause mortality data. Also read | 'Excess deaths in 2020 and 2021 not equal to deaths by COVID-19, increase attributable to several reasons' Our study in Kerala found that 34% of deaths were indirectly attributable to the pandemic, and 9% may have been misclassified. If such patterns exist in a State with a relatively strong public health systems (although the death registration in the prescribed time was around 61% in 2021), the scale of undercounting could be even more pronounced in States such as Gujarat and Madhya Pradesh where discrepancies between excess deaths and official figures are significantly wider. These findings make a compelling case for a systematic inquiry into the full extent of mortality during the pandemic. Policymakers should consider conducting a large-scale study, which could be also accomplished by including questions on decedents in the next Census. More importantly, they must serve as a wake-up call to urgently reform India's mortality surveillance architecture. Shilka Abraham, Master of Public Health graduate, School of Health Systems Studies, Tata Institute of Social Sciences; Soumitra Ghosh, Associate Professor and Chairperson, Centre for Health Policy, Planning and Management, School of Health Systems Studies, Tata Institute of Social Sciences

A Turning Point in Colon Cancer: Young People Are Finding It Earlier
A Turning Point in Colon Cancer: Young People Are Finding It Earlier

Hindustan Times

time6 hours ago

  • Hindustan Times

A Turning Point in Colon Cancer: Young People Are Finding It Earlier

People under age 50 have been appearing increasingly at doctor's offices in the past few decades, complaining of blood in their stool or bowel or of abdominal trouble or unexplained weight loss. The diagnosis: colorectal cancer . And by that time, it was often too late. But that paradigm is finally starting to shift, at least for patients in their 40s. There has been a jump in people aged 45 to 49 getting screened for colorectal cancer, after recent medical guidelines lowered the screening age for those at average risk. As a result, the disease is being caught sooner, when it is more curable and the treatment is less grueling, according to new research from the American Cancer Society. The recent screening recommendations designed to catch cases sooner appear to be working. 'It's thrilling to see this,' said Rebecca Siegel, an epidemiologist at the ACS and an author of the new research. 'It means fewer deaths and higher quality of life for people who are diagnosed.' The findings come in a flurry of research published Monday in the Journal of the American Medical Association. Colorectal cancer screening in the U.S. for adults age 45 to 49 increased by 62% from 2019 to 2023, according to one ACS paper. Early-stage diagnoses then surged, including a 50% relative increase from 2021 to 2022, according to another ACS report. A trial of more than 20,000 people in the same age bracket was published by a separate group of researchers, showing that testing uptake increases when people are mailed stool tests by default, versus when they are asked if they want a test or a colonoscopy. Screening rates in the trial were low, however, with 19% of people in the trial overall opting to get screened. 'We probably shouldn't be wasting time asking patients first; we should send them what they need,' said Dr. Folasade May, the trial's senior author and a gastroenterologist at the University of California, Los Angeles. 'We have a long way to go.' Colorectal cancer rates have been rising for people under age 50 since the 1990s, and the disease is now the leading cause of cancer death among men in that group. Researchers are investigating everything from diet and lifestyle to environmental contaminants, to figure out why colorectal and other cancers are rising in younger adults. The ACS in 2018 started recommending that people with average risk as young as 45 years old get screened for colorectal cancer, down from the previous start of age 50. The U.S. Preventive Services Task Force followed in 2021; their guidelines carry particular weight among primary-care providers and often lead to health-insurance coverage. Suddenly, millions of people were newly overdue for screening. For people in that 45-to-49 age bracket, cases jumped, going from about a 1% increase in the incidence rate each year since 2004 to a 12% annual rise from 2019 to 2022, the data show. The rise was driven by diagnoses of early-stage disease. A post-Covid rebound in people seeking healthcare could contribute to some of the increase, researchers said, but the change in screening guidance is likely the bigger factor. The trend looks similar to what happened among people ages 50 and above in the late 1990s, after screening was first recommended for them, said Caitlin Murphy, a cancer epidemiologist and professor of pediatrics at the University of Chicago, who wasn't involved in the studies. It will still take time to see what the impact on deaths looks like for the newly eligible, she said. 'Ultimately, the goal of screening is to reduce mortality, and we haven't seen that quite yet, simply because not enough time has gone by.' Up-to-date screening via colonoscopy for those aged 45 to 49 rose from around 20% of people in 2019 to about 28% in 2023, according to one of the ACS reports. A colonoscopy is the gold-standard test that also helps doctors remove polyps to actually prevent the cancer from forming. Alternatively, use of tests that look for blood or DNA changes in the stool also increased, rising from 1.3% to 7.1% in that age group. Screening rates remained mostly stable in all other age groups, the report found. Screening rates also remained unchanged for people ages 45 to 49 with less than a high-school education or who are uninsured. And they still trail behind those for older adults, who remain at higher risk. Factors including genetics, excess body weight, smoking cigarettes and a diet heavy in red and processed meats also increase a person's odds of developing the disease. People in the 45-to-49 age bracket account for nearly half of all colorectal cancers under age 50, ACS said. But that still leaves a lot of people who are at risk and are too young to be screened. 'I have patients in their 20s in my practice that would never fit the guidelines,' said Dr. Michael Cecchini, a medical oncologist and colorectal cancer specialist at Yale Cancer Center. 'We need to be thinking about it on our list of possible diagnoses.' Write to Brianna Abbott at

Doctors fight vaccine mistrust as Romania hit by measles outbreak
Doctors fight vaccine mistrust as Romania hit by measles outbreak

Time of India

time9 hours ago

  • Time of India

Doctors fight vaccine mistrust as Romania hit by measles outbreak

Răuceşti: When epidemiologist Daniela Gafita makes her rounds in the remote villages of northeastern Romania to educate communities about the risks of measles, she frequently encounters parents who hesitate to have their children vaccinated. With measles cases in Europe hitting a 25-year high last year, Romania was the country most affected: it recorded 13,000 of the approximately 18,000 cases registered between June 2024 and May 2025 in the European Economic Area, which includes EU members as well as Iceland, Liechtenstein and Norway. But the disease has also re-emerged globally, with the United States confronting its worst epidemic in 30 years, in part fuelled by anti-vaccine misinformation that has been circulating on social media since the Covid-19 pandemic. Despite widespread vaccine scepticism in Romania, Gafita and her colleagues from the local health department are undeterred in their mission to spread the immunisation message. "We are trying to recover little by little what we lost" in the past decades when the situation was still at bay, said the 52-year-old. Romania has the EU's lowest vaccination rate at 62 percent, a far cry from the 95 percent the World Health Organization (WHO) says is needed for effective control. - Irrational fear - But it's a fight on many fronts, due not only to poverty but also poor access to health care and persistent rumours that vaccination causes autism. "I heard the vaccine is dangerous," said a woman, who declined to give her name, in the village of Raucesti. Elena Armenia, who also lives in the village of 7,500 people, told AFP that she did not want her youngest child to be vaccinated after reading "about a link to autism" online, a misconception that has been refuted by the scientific community. "Fear crept into my mind and I can't shake it off," said the 34-year-old. Her neighbours' children recently ended up in hospital after contracting measles, a contagious disease that causes fever, respiratory symptoms and a rash -- but can also lead to pneumonia, brain inflammation and even death. Romania reported eight fatalities from measles between June 2024 to May 2025. In July, a child died in Britain, with three deaths being recorded in the United States this year. Family doctor Monica Apostol told AFP that she was less optimistic than some of her colleagues about Romania's vaccination rate being boosted soon. "I'm hitting a brick wall," she said about her many conversations with parents. - Far-right anti-vaxers - Several factors have contributed to lower vaccination rates and subsequently to the resurgence of measles in Romania, where jabs are offered for free but are not mandatory. Millions of Romanians, including many health professionals, left the country after the end of communism in 1989. Moreover, the country has seen periods of vaccine shortages, but also an underfunded healthcare system and an increasing lack of trust in authorities. During the Covid pandemic, public figures in Romania but also worldwide began launching or endorsing anti-vaccination campaigns, with US President Donald Trump appointing Robert F. Kennedy Jr as health secretary despite his support of anti-vaccine conspiracy theories. Romania's far right also seized on anger over strict pandemic measures and started promoting anti-vaccine beliefs. Far-right leader George Simion, who topped the first round of the presidential election in May before losing in the second round, has said that parents should have the freedom to decide whether to have their children vaccinated or not. Pro-European President Nicusor Dan recently called on authorities to redouble their efforts to "regain people's trust", and combat a deluge of conspiracy theories and fake news that has eroded confidence. "The recent elections have shown that misinformation campaigns are conducted in a highly professional manner," said Gindrovel Dumitra, coordinator for vaccinations at one of Romania's main doctors' associations. Faced with a situation that is "out of control", his colleague Gafita advocates for tougher nationwide rules, including the need for children to be vaccinated to be able to attend school. "Even if such measures are unpopular and contrary to what many people want," she said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store